Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus-Reference-Cited by-同舟云学术

Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus

Published:2023-09-18 Issue:39 Volume:8 Page:35538-35554
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Rabie Amgad M.¹²^ORCID,Abdel-Dayem Marwa A.³,Abdalla Mohnad⁴^ORCID

Affiliation:

1. Dr. Amgad Rabie’s Research Lab. for Drug Discovery (DARLD), Mansoura City 35511, Mansoura, Dakahlia Governorate, Egypt

2. Head of Drug Discovery & Clinical Research Department, Dikernis General Hospital (DGH), Magliss El-Madina Street, Dikernis City 35744, Dikernis, Dakahlia Governorate, Egypt

3. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Horus University─Egypt (HUE), New Damietta 34518, Damietta Governorate, Egypt

4. Key Laboratory of Chemical Biology (Ministry of Education), Department of Pharmaceutics, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 Cultural West Road, Jinan, Shandong Province 250012, PR China

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsomega.2c08073

Reference40 articles.

1. A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals

2. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro

3. Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors “leflunomide” and “teriflunomide” in Covid-19: A narrative review

4. Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19

5. Cyanorona-20: The first potent anti-SARS-CoV-2 agent

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Isoquinoline Derivative "CYNOVID" as a Prospective Anti-SARS-CoV-2 Agent: An Expanded Investigative Computational Study;European Journal of Medicinal Chemistry Reports;2024-09

2. Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study;Expert Review of Anti-infective Therapy;2024-06-27

3. Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases;Expert Review of Anti-infective Therapy;2024-05-08

4. A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds;Drug Design, Development and Therapy;2024-05

5. Application and Development of Targeted Fishing Technology in Natural Product Screening - A Simple Minireview;Current Pharmaceutical Analysis;2024-05